Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

BACKGROUND: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. There is no information...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz, Jaime, Galimard, Jacques-Emmanuel, Labopin, Myriam, Afanasyev, Boris, Angelucci, Emanuele, Ciceri, Fabio, Blaise, Didier, Cornelissen, Jan J., Meijer, Ellen, Diez-Martin, J. L., Koc, Yener, Rovira, Montserrat, Castagna, Luca, Savani, Bipin, Ruggeri, Annalisa, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201995/
https://www.ncbi.nlm.nih.gov/pubmed/32375860
http://dx.doi.org/10.1186/s13045-020-00882-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201995/
https://www.ncbi.nlm.nih.gov/pubmed/32375860
http://dx.doi.org/10.1186/s13045-020-00882-6

Ejemplares similares